Stiller, B., Stefanelli, A., Schueffl, H., Mathuber, M., Skorokhyd, N., Gufler, J., Pirker, C., Holcmann, M., Panchuk, R., Sibilia, M., Marko, D., Berger, W., Kowol, C. R., Hager, S., & Heffeter, P. (2025). The anticancer thiosemicarbazone triapine exerts immune-enhancing activities via immunogenic cell death induction and FAS upregulation. Experimental Hematology and Oncology, 14(1), Artikel 109. https://doi.org/10.1186/s40164-025-00700-0

Hager, S., Jaunecker, C., Schmutz, C., Plaza, C., Bastos-Moreira, Y., Varga, E., Berger, W., & Marko, D. (2025). Anthocyanin-rich elderberry extract during chemotherapy: Berry good or berry bad? Toxicology Letters, 411(Supplement: S), S144-S145. https://doi.org/10.1016/j.toxlet.2025.07.356

Behr, A. C., Fæste, C. K., Azqueta, A., Tavares, A. M., Spyropoulou, A., Solhaug, A., Olsen, A. K., Vettorazzi, A., Mertens, B., Zegura, B., Streel, C., Ndiaye, D., Spilioti, E., Dubreil, E., Buratti, F. M., Crudo, F., Eriksen, G. S., Snapkow, I., Teixeira, J. P., ... Dietrich, J. (2025). Hazard characterization of the mycotoxins enniatins and beauvericin to identify data gaps and improve risk assessment for human health. Archives of Toxicology, 99(5), 1791-1841. https://doi.org/10.1007/s00204-025-03988-3

Gufler, J., Heffeter, P., Kowol, C. R., Hager, S., & Marko, D. (2025). Opposing effects of mycotoxins alternariol and deoxynivalenol on the immunomodulatory effects of oxaliplatin and triapine. Toxicology, 511, Artikel 154039. https://doi.org/10.1016/j.tox.2024.154039

Stiller, B., Hager, S., Filipović, N. R., Kowol, C. R., & Heffeter, P. (Angenommen/Im Druck). Schiff bases and cancer drug resistance: key preclinical breakthroughs. Future Medicinal Chemistry. https://doi.org/10.1080/17568919.2025.2561540

Gufler, J., Max, M., Hager, S., & Marko, D. (2025). The mycotoxin zearalenone and its metabolite α-zearalenol interfere with breast cancer therapy. Toxicology Letters, 411(Supplement: S). https://doi.org/10.1016/j.toxlet.2025.07.340

Labuda, R., Bacher, M., Rosenau, T., Gratzl, H., Doppler, M., Hager, S., Marko, D., Wiesner, C., Očková, M., Ollinger, N., Wagner, M., Schüller, C., & Strauss, J. (2024). Chemical composition of anti-microbially active fractions derived from extract of filamentous fungus Keratinophyton Lemmensii including three novel bioactive compounds. Scientific Reports, 14(1), Artikel 25310. https://doi.org/10.1038/s41598-024-75510-1

Louro, H., Vettorazzi, A., López de Cerain, A., Spyropoulou, A., Solhaug, A., Straumfors, A., Behr, A. C., Mertens, B., Žegura, B., Fæste, C. K., Ndiaye, D., Spilioti, E., Varga, E., Dubreil, E., Borsos, E., Crudo, F., Eriksen, G. S., Snapkow, I., Henri, J., ... Marko, D. (2024). Correction to: Hazard characterization of Alternaria toxins to identify data gaps and improve risk assessment for human health (Archives of Toxicology, (2024), 98, 2, (425-469), 10.1007/s00204-023-03636-8). Archives of Toxicology, 98(10), 3513-3514. https://doi.org/10.1007/s00204-024-03818-y

Cai, Z., Li, W., Hager, S., Wilson, J. L., Afjehi-Sadat, L., Heiss, E. H., Weichhart, T., Heffeter, P., & Weckwerth, W. (2024). Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through α-ketoglutarate and mTORC1 signaling. Cellular and Molecular Immunology, 21(5), 448-465. https://doi.org/10.1038/s41423-024-01134-0

Louro, H., Vettorazzi, A., López de Cerain, A., Spyropoulou, A., Solhaug, A., Straumfors, A., Behr, A. C., Mertens, B., Žegura, B., Fæste, C. K., Ndiaye, D., Spilioti, E., Varga, E., Dubreil, E., Borsos, E., Crudo, F., Eriksen, G. S., Snapkow, I., Henri, J., ... Marko, D. (2024). Hazard characterization of Alternaria toxins to identify data gaps and improve risk assessment for human health. Archives of Toxicology, 98(2), 425-469. https://doi.org/10.1007/s00204-023-03636-8

Gufler, J., Marko, D., Heffeter, P., & Hager, S. (2024). Opposite effects of food mycotoxins altemariol and deoxynivalenol on the immunomodulatory properties of anticancer drug oxaliplatin. Naunyn-Schmiedeberg's Archives of Pharmacology, 397(Suppl.1), S75-S76. Artikel P244.

Schaier, M., Falcone, E., Prstek, T., Vileno, B., Hager, S., Keppler, B. K., Heffeter, P., Koellensperger, G., Faller, P., & Kowol, C. R. (2023). Human serum albumin as a copper source for anticancer thiosemicarbazones. Metallomics, 15(8), Artikel mfad046. https://doi.org/10.1093/mtomcs/mfad046

Strasser, P., Montsch, B., Weiss, S., Sami, H., Kugler, C., Hager, S., Schueffl, H., Mader, R., Brüggemann, O., Kowol, C. R., Ogris, M., Heffeter, P., & Teasdale, I. (2023). Degradable Bottlebrush Polypeptides and the Impact of their Architecture on Cell Uptake, Pharmacokinetics, and Biodistribution In Vivo. Small, 19(22), Artikel 2300767. https://doi.org/10.1002/smll.202300767